The results of clinical study of the drug Pikamilon 
(analysis of data of neurologic and psychiatric clinics)


A. P. Huaichenko, R.P. Kruglikova-Lvova

Abstract

The analysis of results of pikamilon clinical investigation in 16 neurologic and psychiatric clinics on 984 patients with various diseases is presented.  Pikamilon efficiency and good tolerance were established.  Pikamilon was recommended by the Pharmacological Committee of the Ministry of Health of the USSR for application in medicine for insults therapy, for treatment of transient disorders and chronic insufficiency of blood circulation and also as a tranquillizer without the sedative component and myorelaxation;  Pikamilon is recommended for asthenic disorders within the limits of different psychical diseases and for treating depressions of old age.  As a therapeutic and prophylactic remedy, pikamilon is recommended for rehabilitation of capacity for work and for increasing of stability towards physical and psychological burden.  Pikamilon is used in narcology in the period of abstinence.

cataract | Galantamine | Vinpocetine | Idebenone | Pyritinol | Modafinil
Deprenyl | Piracetam
| CDP Choline  Memantine | stroke | benfotiamine
 Home | Order
www.AlzheimersTreatments.com

 

 

Hit Counter